Skip to Content
Merck
CN

LC/MS/MS Analysis of Immunosuppressant Drugs on apHera C18

LC/MS/MS Analysis of Immunosuppressant Drugs on apHera™ C18 application for HPLC

Materials

related product

Product No.
Description
Pricing

apHera C18 HPLC Column

5 μm particle size, L × I.D. 15 cm × 2 mm

Ascomycin solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Cyclosporin A solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Cyclosporin D solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Sirolimus solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Tacrolimus solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

mobile phase

[A] 0.1% formic acid water; [B] 0.1% formic acid in 98:2 (v/v) acetonitrile:water

gradient

50% B for 2 min; to 100% B in 2 min; held for 2 min

flow rate

0.4 mL/min

column temp.

65 °C

detector

MS, ESI(+), MRM

sample

300 ng/mL in (4:1) 1% formic acid acetonitrile:water

injection

5 μL

column

apHera C18, 15 cm x 2.1 mm I.D., 5 μm particles (56100AST)

Description

Analysis Note

The apHera C18 HPLC column packed with polymeric particles demonstrated excellent peak shape and rapid elution for these bulky, immunosuppressant compounds under conditions not permitted by silica-based HPLC columns. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

Legal Information

apHera is a trademark of Sigma-Aldrich Co. LLC